| __timestamp | Celldex Therapeutics, Inc. | Novo Nordisk A/S |
|---|---|---|
| Wednesday, January 1, 2014 | 104381000 | 13762000000 |
| Thursday, January 1, 2015 | 100171000 | 13608000000 |
| Friday, January 1, 2016 | 102726000 | 14563000000 |
| Sunday, January 1, 2017 | 96171000 | 14014000000 |
| Monday, January 1, 2018 | 66449000 | 14805000000 |
| Tuesday, January 1, 2019 | 42672000 | 14220000000 |
| Wednesday, January 1, 2020 | 42534000 | 15462000000 |
| Friday, January 1, 2021 | 53311000 | 17772000000 |
| Saturday, January 1, 2022 | 82258000 | 24047000000 |
| Sunday, January 1, 2023 | 118011000 | 32443000000 |
| Monday, January 1, 2024 | 48062000000 |
Unleashing the power of data
In the ever-evolving world of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Novo Nordisk A/S and Celldex Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment.
From 2014 to 2023, Novo Nordisk A/S has consistently prioritized R&D, with expenditures growing by over 135%. By 2023, their R&D spending reached a staggering $32.4 billion, underscoring their dedication to advancing diabetes care and other therapeutic areas.
In contrast, Celldex Therapeutics, Inc. maintained a more modest R&D budget, peaking at $118 million in 2023. Despite a 13% increase from 2014, their focus remains on niche oncology treatments.
This comparison highlights the diverse strategies within the pharmaceutical sector, where both giants and niche players contribute to medical advancements.
Comparing Innovation Spending: Eli Lilly and Company and Novo Nordisk A/S
Research and Development: Comparing Key Metrics for Novo Nordisk A/S and TG Therapeutics, Inc.
Comparing Innovation Spending: Novo Nordisk A/S and Agios Pharmaceuticals, Inc.
Research and Development Investment: AbbVie Inc. vs Celldex Therapeutics, Inc.
Intra-Cellular Therapies, Inc. or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Summit Therapeutics Inc. or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Verona Pharma plc and Celldex Therapeutics, Inc.
Research and Development Investment: Apellis Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.
Analyzing R&D Budgets: Supernus Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Wave Life Sciences Ltd. and Celldex Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Amphastar Pharmaceuticals, Inc. and Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Celldex Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc.